An ongoing genetic battle?

Nature

Volumn 429, Issue 6994, 2004, Pages 819-822

  Srivastava, Deepak ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; PATIENT TREATMENT;

FUNCTIONAL PROBLEMS; HEARTS; PHYSICAL DEFECTS;

GENETIC ENGINEERING;

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 10; REGULATOR PROTEIN; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR TBX5; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; NKX2 5 PROTEIN, MOUSE; NKX2-5 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

MEDICINE;

CARDIOVASCULAR FUNCTION; CONGENITAL HEART DISEASE; GENE MUTATION; GENETIC RISK; HEART DEVELOPMENT; HUMAN; MOUSE; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; SHORT SURVEY; ANIMAL; ARTICLE; CHILD; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; DISEASE MODEL; GENETICS; HEART VENTRICLE; METABOLISM; MUTATION; NEWBORN; PATHOPHYSIOLOGY;

ANIMALS; CHILD; DISEASE MODELS, ANIMAL; HEART DEFECTS, CONGENITAL; HEART VENTRICLES; HOMEODOMAIN PROTEINS; HUMANS; INFANT, NEWBORN; MICE; MUTATION; TRANSCRIPTION FACTORS;

EID: 3042802511     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/429819a     Document Type: Short Survey

References (9)

1. Hoffman, J. I. E. & Kaplan, S. J. Am. Coll. Cardiol. 39, 1890-1900 (2002).
2. Pashmforoush, M. et al. Cell 117, 373-386 (2004).
3. Bodmer, R. Development, 118, 719-729 (1993).
4. Lyons, I. et al. Genes Dev. 9, 1654-1666 (1995).
5. Schott, J. J. et al. Science 281, 108-111 (1998).
6. Basson, C. T. et al. Nature Genet. 15, 30-35 (1997).
7. Bruneau, B. G. et al. Cell 106, 709-721 (2001).
8. Garg, V. et al. Nature 424, 443-447 (2003).
9. Srivastava, D. Annu. Rev. Physiol. 63, 451-470 (2001).